Kimberly Ha/LinkedIn
Apr 3, 2026, 17:33
Kimberly Ha: Epia Neuro Aims to Restore Movement in Stroke Survivors
Kimberly Ha, Founder and CEO at KKH Advisors, shared a post on LinkedIn:
”Epia Neuro is the latest medtech startup looking to tap the potential of brain-computer interface (BCI) technology, launching with a device that aims to turn brain signals into digital commands.
The San Francisco-based company is focusing its neural interface platform initially on stroke survivors.
The platform combines a minimally invasive, long-lifetime read/write brain-computer interface (pictured above) with assistive devices and AI-driven support, aiming to help stroke survivors translate neural signals into functional movement, according to an April 2 release.”
Stay updated with Hemostasis Today.
-
Apr 3, 2026, 17:28Ryan Perry: Heart and Stroke Announces 2026 Grants-in-Aid Indigenous Research Stream Funding Opportunity
-
Apr 3, 2026, 17:21Maxime Dely: A Meaningful Journey of 14 years in Blood Transfusion
-
Apr 3, 2026, 17:19Arun V J: Don’t Miss TRANSCON 2026 – A Direct Pathway Into India’s Clinical and Institutional Network
-
Apr 3, 2026, 17:17Louise St. Germain Bannon: Preparating for ISTH 2026 and Highlighting Best Aspects of Congress
-
Apr 3, 2026, 17:15Jeremy Jacobs: The Political Misuse of ‘Patient Autonomy’ in Modern Law
-
Apr 3, 2026, 17:14Yves Bikorimana: When More Is Not Better – Polycythemia
-
Apr 3, 2026, 17:14Congratulations to Vikram Huded On His New Role as The President of The Indian Stroke Association – Voice of Healthcare
-
Apr 3, 2026, 17:12Pedro Perez: Timing Is the Biggest Challenge in Treating DVT
-
Apr 3, 2026, 17:11Augustina Isioma Ikusemoro: Kell vs RhD Sensitization – The Difference in RBC Destruction